Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why RingCentral (RNG), Stratasys (SSYS) and 3 Other Stocks Are Making Big Moves Today

Better-than-expected financial results in the banking sector are driving the markets up on Thursday, as the U.S dollar continues to surge for the third consecutive day. Oil is also up marginally. While many stocks are on the rise, we are of course seeing some big movers in both directions today. Let’s take a look into Argos Therapeutics Inc (NASDAQ:ARGS), RingCentral Inc (NYSE:RNG), Stratasys, Ltd. (NASDAQ:SSYS), First Republic Bank (NYSE:FRC), and Dominion Diamond Corp (NYSE:DDC), five of the day’s big movers, and see what has triggered their volatility. We’ll also check in on how the hedge funds in our database were trading these companies in the fourth quarter.

At Insider Monkey, we track more than 785 hedge funds, whose 13F filings we analyze as part of our small-cap strategy. Our research has shown that imitating a portfolio that includes the 15 most popular small-cap stocks among hedge funds can outperform the market by as much as 95 basis points per month on average (see more details here).

Argos Continues To Rally

Back to the stocks that interest us, let’s start with Argos Therapeutics Inc (NASDAQ:ARGS), a small-cap biopharmaceutical company that is up by more than 13.6% on Thursday afternoon, in what seems to be a continuation of the strong uptrend experienced by the stock since the beginning of the year. Year-to-date, the shares have gained more than 360%, based largely on a fourth quarter earnings beat, a financing plan and the initiation of a Phase 2 trial of AGS-003 for the treatment of Non-Small Cell Lung Cancer.

By the end of the fourth quarter of 2015, Argos Therapeutics Inc (NASDAQ:ARGS) counted only two supporters among the funds that we track. One of them was Anand Parekh’s Alyeska Investment Group, which disclosed ownership of 202,144 shares of the company.

Follow Argos Therapeutics Inc
Trade (ARGS) Now!

RingCentral’s Partner Program Now A 5-Star Option

Next up is RingCentral Inc (NYSE:RNG), a small-cap SaaS solutions provider that is trading up by 8% today after CRN gave its Partner Program a 5-Star rating in its 2016 Partner Program Guide. “This annual guide is the definitive listing of technology vendors that service solution providers, or provide products through the IT channel. The 5-Star Partner Program Guide rating recognizes an elite subset of companies that offer solution providers the best partnering elements in their channel programs,” a press release reads.

RingCentral Inc (NYSE:RNG) is considerably more popular among hedge funds than Argos Therapeutics. At the end of the fourth quarter, the company counted 26 supporters among the firms that we keep track of and those funds held 16% of the company’s shares on December 31. A noteworthy position was that of Donald Chiboucis’ Columbus Circle Investors, which held 2.6 million shares of the company after increasing its stake by 73% over the October-to-December period.

Follow Ringcentral Inc. (NYSE:RNG)
Trade (NYSE:RNG) Now!

We have the latest on three more big movers on the next page.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.